Alimera Sciences Inc logo

Alimera Sciences Inc Share Price (NASDAQ: ALIM)

Last updated on

Bell Icon

This instrument is not available for trading on the INDmoney app on 13 Sep 2024

Check the interactive Alimera Sciences Inc Stock chart to analyse performance

Alimera Sciences Inc Key Stats

Check Alimera Sciences Inc key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$0.0
Open
$5.55
Market Capitalization
$301.3M
Today's Volume
$2.7M
Revenue TTM
$99.7M
EBITDA
$14.8M
Earnings Per Share (EPS)
$1.05
PE Ratio
5.28
Profit Margin
-14.74%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-34.57%

Global Institutional Holdings in Alimera Sciences Inc

  • Name

    Holdings %

  • Caligan Partners LP

    30.96%

  • Velan Capital Investment Management LP

    25.02%

  • Stonepine Capital Management Llc

    6.46%

  • BOOTHBAY FUND MANAGEMENT, LLC

    5.88%

  • Altium Capital Management, LP

    3.95%

  • BlackRock Inc

    2.55%

Analyst Recommendation on Alimera Sciences Inc Stock

Rating
Trend

Buy

    90%Buy

    10%Hold

    0%Sell

Based on 10 Wall street analysts offering stock ratings for Alimera Sciences Inc(by analysts ranked 0 to 5 stars)

About Alimera Sciences Inc

Alimera Sciences, Inc., a pharmaceutical company, develops and commercializes prescription ophthalmic retinal pharmaceuticals. It operates through United States, International, and Operating Cost segments. The company offers ILUVIEN, a fluocinolone acetonide intravitreal implant for the treatment of diabetic macular edema (DME), which is a disease of the retina that affects individuals with diabetes and can lead to severe vision loss and blindness; and to prevent relapse in recurrent non-infectious uveitis affecting the posterior segment of the eye (NIU-PS). It also provides YUTIQ, a fluocinolone acetonide intravitreal implant to treat NIU-PS. The company sells its products to physician offices, clinics, pharmacies, and hospitals through direct sales and distributors. It has a collaboration agreement with EyePoint Pharmaceuticals US, Inc. to develop, manufacture, and sell products including YUTIQ for the treatment and prevention of uveitis; and Ocumension (Hong Kong) Limited for the development and commercialization of the company's 190 microgram fluocinolone acetonide intravitreal implant in applicator for the treatment and prevention of eye diseases. Alimera Sciences, Inc. was incorporated in 2003 and is headquartered in Alpharetta, Georgia.
Organization
Alimera Sciences Inc
Employees
154
CEO
Mr. Richard S. Eiswirth Jr.
Industry
Health Technology

Important FAQs about investing in ALIM Stock from India :

What is Alimera Sciences Inc share price today?

Alimera Sciences Inc share price today is as on at the close of the market. Alimera Sciences Inc share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Alimera Sciences Inc share?

Alimera Sciences Inc share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Alimera Sciences Inc stock price today i.e. is closed at , lower by 100% versus the 52 week high.

How to invest in Alimera Sciences Inc Stock (ALIM) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Alimera Sciences Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Alimera Sciences Inc Shares .

What is the minimum amount required to buy Alimera Sciences Inc Stock (ALIM) from India?

Indian investors can start investing in Alimera Sciences Inc (ALIM) shares with as little as ₹92.5925 or $1 (as of March 19, 2026) using the INDmoney app.
For example: If you want to invest $10 or ₹925.92 in Alimera Sciences Inc stock (as per the Rupee-Dollar exchange rate as on March 19, 2026). Learn more about fractional shares .

What are the returns that Alimera Sciences Inc has given to Indian investors in the last 5 years?

Alimera Sciences Inc stock has given 0.0% share price returns and 27.59% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?